• Product NameUlipristal acetate
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityUlipristal acetate(CDB2914) is a novel selective progesterone receptor modulator (SPRM) for the treatment of benign gynecological conditions such as uterine myoma.
• Target NameEstrogen/progestogen Receptor
• CAS No. 126784-99-4
• Calculated MW 475.62
• Formulation C30H37NO4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Endocrine system
  SMILES:CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C
  Pathways:Endocrinology/Hormones
  Receptor:PR
  Boling pt:
  Melting pt:183-185C
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Pohl O, et al. Int J Clin Pharmacol Ther. 2013 Jan;51(1):26-33.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting